While scientists race to find a vaccine for the coronavirus, countries including Malaysia are resorting to convalescent blood plasma transfusion to treat patients severely ill with COVID-19. The treatment includes administering blood plasma from patients who have recovered from COVID-19 to patients critically ill with the novel respiratory illness. We asked experts to comment on the effectiveness of this method to treat newly-infected patients.
Science Media Centre Malaysia is an information resource centre aimed at promoting accurate and evidence-based reporting especially on complex or controversial science issues in the media. We connect journalists to credible and articulate scientists from across various research fields. We also help scientists to communicate their research effectively and ultimately make science mainstream and accessible to the public.
You must be logged in to post a comment.